Gilead Sciences’ Statement on Remdesivir
Press Release
LANGUAGES
English
اردو
About Us
History
Company Profile
Vision, Mission & Values
Message From CEO
Board of Directors
Contact Us
Partnerships
Product Portfolio
Pharmaceuticals
Medical Technologies
Exports
Investors
Company Profile
Governance
Board of Directors
Shareholding Pattern
Name of Auditor & Legal Advisor
Investor Relations
Online Form & Contact Person
Notices of General Meetings, Dividend / Bonus Declarations
Sitemap
Search
Media
Awards
Memberships
News & Updates
Website Last Updated
Election of Directors
Notice of Election of Directors
Detail of Submitted Proxies
Profile of Contesting Candidates
List of Shareholders
Proxy Form
Ballot Paper
Investor Information
PSX Symbol
Financial Ratios
Share Registrar
Free Float
Code of Conduct
Shareholding Information
List of Non CNIC Shareholders
List of Unclaimed Dividends And Shares
Share Price
Financial Statements
Annual Reports
Interim Accounts
Financial Reports
Compliance Certificate
EHS Policy
Patients
Disease Info
Drug Safety
Send Query
Physicians
CSR
Press & Media
Videos
Notice of General Meetings
Notice of Extraordinary General Meeting 2021
English /
Urdu
Proxy Form
Form of Proxy 2021
English /
Urdu
Dividend/Bonus Declarations
Site Map
TOP